Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin C pseudogene 30 (ELOCP30)
- Target
- ELOCP30
- Molecular classification
- Pseudogene, Other
01
Overview
Elongin C pseudogene 30 (ELOCP30) is a non-coding pseudogene that shares sequence similarity with the functional elongin C gene. It is annotated in genomic databases as TCEB1P30 and is not known to encode a functional protein, participate directly in cellular pathways, or act as a therapeutic target. Pseudogenes such as ELOCP30 are produced by genomic rearrangements and mutation, and while some pseudogenes have regulatory functions impacting disease and gene networks, no such roles have been reported for ELOCP30. There are no known drugs, biomarker applications, or safety issues associated with this molecule.
- Other names
- TCEB1P30Elongin C pseudogene 30
02
Mechanism of action
None known for drugs, as ELOCP30 is not a target
03
Biological functions
None reported for ELOCP30 specificallyGenerally, pseudogenes may participate in gene regulation via decoy mechanisms for miRNAs, but this has not been described for ELOCP30 itself
04
Disease associations
None established for ELOCP30Pseudogenes in general sometimes play roles in cancer and other diseases via gene regulation, but no evidence links ELOCP30 directly to disease
05
Safety considerations
None known, as ELOCP30 is not therapeutically targeted
06
Interacting drugs
None known
07
Biomarkers
None known for ELOCP30Some pseudogenes are used as biomarkers, but ELOCP30 is not cited in this context
Beyond the preview
Go deeper on Elongin C pseudogene 30 (ELOCP30).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elongin C pseudogene 30 (ELOCP30).